JR14a
JR14a is a potent thiophene antagonist of human complement C3a receptor. JR14a shows selectivity for the human C3a receptor over C5a receptor. JR14a can suppress C3aR-mediated inflammation[1].
Product Specifications
CAS Number
[2411440-41-8]
UNSPSC
12352005
Hazard Statement
H315, H319
Target
Complement System
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jr14a.html
Purity
99.59
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C(SC(C(C(C=C1)=CC=C1Cl)C(C=C2)=CC=C2Cl)=C3)=C3C)N[C@H](C(O)=O)CCCNC(N)=N
Molecular Formula
C25H26Cl2N4O3S
Molecular Weight
533.47
Precautions
H315, H319
References & Citations
[1]Rowley JA, et, al. Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity. J Med Chem. 2020 Jan 23;63 (2) :529-541.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6270999-01 0.1 mL
ACOT9, ID (ACOT9, Acyl-coenzyme A thioesterase 9, mitochondrial, Acyl-CoA thioester hydrolase 9) (MaxLight 650)
Ask
View Details 
MBS6270999-02 5x 0.1 mL
ACOT9, ID (ACOT9, Acyl-coenzyme A thioesterase 9, mitochondrial, Acyl-CoA thioester hydrolase 9) (MaxLight 650)
Ask
View Details MBS6316293-01 0.1 mL
LIN7B, NT (LIN7B, MALS2, VELI2, Protein lin-7 homolog B, Mammalian lin-seven protein 2, Vertebrate lin-7 homolog 2) (MaxLight 750)
Ask
View Details